00000000cam 2200000zi 4500
0019.956901
003CaOODSP
00520251110111931
006m     o  d f      
007cr |n|||||||||
008251030e199811##onc     ob   f|0| 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-406/1998E-PDF
24500|aReport of the Canadian Veterinary Medical Association Expert Panel on rbST.
264 1|a[Ottawa] : |bHealth Canada, |cNovember 1998.
300 |a1 online resource (295 unnumbered pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Rapport du comité d'experts sur la STbr de l'Association canadienne des vétérinaires.
500 |aCaption title.
500 |a"Archived."
500 |a"Unclassified."
504 |aIncludes bibliographical references (pages [120-156]).
520 |a"At Health Canada's request, the Canadian Veterinary Medical Association (CVMA) established anExpert Panel to review the issues of the efficacy and safety of recombinant bovine somatotropin (rbST)... The Panel reviewed material provided by Health Canada from Monsanto's submission to have rbST (sometribove) approved for use in Canada and carried out an extensive review of the published literature on the subject"--Executive Summary, page[4].
61020|aCanadian Veterinary Medical Association.
650 0|aRecombinant bovine somatotropin|zCanada.
650 0|aAnimal welfare|zCanada.
650 0|aMilk yield|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tRapport du comité d'experts sur la STbr de l'Association canadienne des vétérinaires.|w(CaOODSP)9.957225
85640|qPDF|s1.93 MB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-406-1998-eng.pdf